bioAffinity Technologies Launches Study to Expand CyPath® Lung Technology for Asthma and COPD
bioAffinity Technologies has announced a new study in collaboration with Brooke Army Medical Center aimed at evaluating new diagnostic tests that could enhance the diagnosis and treatment of asthma and chronic obstructive pulmonary disease (COPD) using their CyPath® Lung technology.
SAN ANTONIO–(BUSINESS WIRE)—- $BIAF #AI–bioAffinity Technologies announces study with Brooke Army Medical Center to evaluate new diagnostic tests to improve treatment for asthma and COPD